Targeted radiation after prostate surgery shows promise in cancer control
NCT ID NCT03541850
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a special type of radiation called stereotactic body radiotherapy (SBRT) can help prevent prostate cancer from coming back after surgery. About 92 men who had their prostate removed and have signs of remaining cancer will receive SBRT. The goal is to see if this treatment can keep PSA levels low and manage side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSA LEVEL GREATER THAN 0.03 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
-
USC Norris Comprehensive Cancer Center and Hospital
Los Angeles, California, 90033, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fewer needles, same safety? new study tests smarter prostate cancer detection.
- New combo attack on hard-to-treat prostate cancer shows promise
- Proton beam therapy aims to cut prostate cancer treatment time and side effects
- New drug combo tested to stop prostate cancer spread before surgery
- New hope for hard-to-treat prostate cancer: adding immunotherapy to current drug
- New hope for tough prostate cancer: drug cocktails under trial